Press Releases

Complementary, Scalable Medical and Adult-Use Cannabis Businesses Strengthen Leadership Position in Canada ; Expands U.S. and International Reach   through World-Class Cultivation, Manufacturing, Diversified Product Portfolio and Distribution Footprint Robust Supply Chain and Operational

BERLIN & FRANKFURT, Germany --(BUSINESS WIRE)--Dec. 2, 2020-- Tilray, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a leading company in the manufacture, research and distribution of medical cannabis, announced that it has entered into a co-promotion agreement with Hormosan for its full-spectrum

NANAIMO, British Columbia --(BUSINESS WIRE)--Nov. 24, 2020-- Tilray, Inc. (“ Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that it has entered into privately negotiated exchange agreements with certain

NANAIMO, British Columbia --(BUSINESS WIRE)--Nov. 23, 2020-- Tilray, Inc. (“ Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that it has entered into a privately negotiated exchange agreement with a certain

Total Revenue of $51.4 Million was Flat Versus Q3 2019 and Up 2.0% Compared to Q2 2020 - Excluding Bulk Sales in the Prior Year Period, Total Revenue Increased 25% Total Annualized Savings of Approximately $55 Million to be Achieved by Q4 2020 Net Loss of $(2.3) Million Versus Net Loss of $(36.4)

NANAIMO, British Columbia --(BUSINESS WIRE)--Oct. 28, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the third quarter ended September 30, 2020 on Monday,

Cann­abis-infused gummies expand High Park’s existing line-up of edible brands and products TORONTO --(BUSINESS WIRE)--Oct. 5, 2020-- High Park Holdings Ltd. (“High Park”), a wholly-owned subsidiary of Tilray, Inc. (NASDAQ: TLRY), today announced the newest addition to its cannabis-infused edible

NANAIMO, B.C. --(BUSINESS WIRE)--Sep. 28, 2020-- Tilray, Inc. (NASDAQ: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that Australian researchers have published preliminary results finding that one of the company’s GMP-produced products is

Revenue Increased 10% to $50.4 Million ( C$69.4 Million ) versus Q2 2019 Cost Savings of $13.0 Million Realized in Q2 2020 – on Pace for Total Annualized Savings of Approximately $55 Million   Net Loss of ($81.7) Million increased $45.4 Million versus Q2 2019 Partially Due to Facilities Closure and

NANAIMO, British Columbia --(BUSINESS WIRE)--Jul. 27, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the second quarter ended June 30, 2020 on Monday, August